• Je něco špatně v tomto záznamu ?

Soluble RAGEs and cardiovascular risk factors in adult offspring of patients with premature coronary heart disease

P. Karnosová, M. Mateřánková, J. Seidlerová, O. Mayer, J. Filipovský, V. Karnos,

. 2020 ; 29 (2) : 87-94. [pub] 20191106

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc20028293

Purpose: Advanced glycation end products (AGEs) are a heterogeneous group of highly oxidant compounds which can potentiate microvascular and macrovascular complications through the formation of irreversible cross-links between molecules in the basal membrane and also by engaging the receptor for AGEs (RAGE). Soluble receptor for AGEs (sRAGE) is suggested to have a protective role neutralizing the toxic action of AGEs. We aimed to investigate differences in plasma levels of sRAGE alongside with classic cardiovascular risk factors between offspring of patients with early onset of coronary heart disease (CHD) and healthy controls.Materials and methods: In a cross-sectional design, we examined 114 adult offspring of patients with premature CHD and 194 controls. Concentrations of soluble RAGE were quantified by ELISA methods. Aortic PWV was measured using Sphygmocor device. Multivariate logistic regressions were used to compare differences between the offspring and controls.Results: In the offspring group there were more men (p = 0.023), both groups had similar age (28.5 vs. 28.9 years; p = 0.51). After adjustment for covariates, we observed significantly higher aPWV (6.17 vs. 5.82 m s-1; p = 0.001) and lower sRAGE (1308.11 vs. 1475.59; p = 0.009) in the offspring group compared to controls. The significant determinants of the intergroup difference were sRAGE (p = 0.0017), aPWV (p = 0.011) and current smoking (p = 0.0053).Conclusion: Offspring of patients with early onset of CHD compared to age-matched healthy controls had significantly lower sRAGE levels suggesting a shift in the oxidative balance between stressors and defence mechanisms that may influence a higher cardiovascular risk in the future. The measurement of sRAGE might be a valuable predictor for more precise stratification of cardiovascular risk.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20028293
003      
CZ-PrNML
005      
20250325143240.0
007      
ta
008      
210105s2020 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1080/08037051.2019.1685372 $2 doi
035    __
$a (PubMed)31691578
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Karnosová, Petra, $u Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic. Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic. $d 1985- $7 xx0330667
245    10
$a Soluble RAGEs and cardiovascular risk factors in adult offspring of patients with premature coronary heart disease / $c P. Karnosová, M. Mateřánková, J. Seidlerová, O. Mayer, J. Filipovský, V. Karnos,
520    9_
$a Purpose: Advanced glycation end products (AGEs) are a heterogeneous group of highly oxidant compounds which can potentiate microvascular and macrovascular complications through the formation of irreversible cross-links between molecules in the basal membrane and also by engaging the receptor for AGEs (RAGE). Soluble receptor for AGEs (sRAGE) is suggested to have a protective role neutralizing the toxic action of AGEs. We aimed to investigate differences in plasma levels of sRAGE alongside with classic cardiovascular risk factors between offspring of patients with early onset of coronary heart disease (CHD) and healthy controls.Materials and methods: In a cross-sectional design, we examined 114 adult offspring of patients with premature CHD and 194 controls. Concentrations of soluble RAGE were quantified by ELISA methods. Aortic PWV was measured using Sphygmocor device. Multivariate logistic regressions were used to compare differences between the offspring and controls.Results: In the offspring group there were more men (p = 0.023), both groups had similar age (28.5 vs. 28.9 years; p = 0.51). After adjustment for covariates, we observed significantly higher aPWV (6.17 vs. 5.82 m s-1; p = 0.001) and lower sRAGE (1308.11 vs. 1475.59; p = 0.009) in the offspring group compared to controls. The significant determinants of the intergroup difference were sRAGE (p = 0.0017), aPWV (p = 0.011) and current smoking (p = 0.0053).Conclusion: Offspring of patients with early onset of CHD compared to age-matched healthy controls had significantly lower sRAGE levels suggesting a shift in the oxidative balance between stressors and defence mechanisms that may influence a higher cardiovascular risk in the future. The measurement of sRAGE might be a valuable predictor for more precise stratification of cardiovascular risk.
650    _2
$a dospělí $7 D000328
650    12
$a dospělé děti $7 D032721
650    _2
$a věk při počátku nemoci $7 D017668
650    _2
$a biologické markery $x krev $7 D015415
650    _2
$a studie případů a kontrol $7 D016022
650    12
$a dítě postižených rodičů $7 D016241
650    12
$a koronární nemoc $7 D003327
650    _2
$a průřezové studie $7 D003430
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a rizikové faktory kardiovaskulárních chorob $7 D000082742
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a receptor pro konečné produkty pokročilé glykace $x krev $7 D000067759
650    _2
$a hodnocení rizik $7 D018570
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Mateřánková, Markéta $u Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic. Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.
700    1_
$a Seidlerová, Jitka $u Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic. Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.
700    1_
$a Mayer, Otto $u Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic. Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.
700    1_
$a Filipovský, Jan $u Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic. Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.
700    1_
$a Karnos, Václav $u Department of Surgery, University Hospital in Pilsen, Pilsen, Czech Republic.
773    0_
$w MED00000810 $t Blood pressure $x 1651-1999 $g Roč. 29, č. 2 (2020), s. 87-94
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31691578 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20210105 $b ABA008
991    __
$a 20250325143241 $b ABA008
999    __
$a ok $b bmc $g 1608628 $s 1119473
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 29 $c 2 $d 87-94 $e 20191106 $i 1651-1999 $m Blood pressure $n Blood Press $x MED00000810
LZP    __
$a Pubmed-20210105

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...